Background: The key neuropathological feature of Alzheimer disease (AD) is the accumulation of extracellular β-amyloid (Aβ) plaques in the brain which begins long before clinical signs of dementia. Immunotherapies targeting Aβ may prevent Aβ accumula...

Grundlagenforschung - 01.06.2020 - 30.05.2022

Automatisch geschlossen

Projektleitung: Felbecker Ansgar
Mitarbeiter/innen: Schneider Thomas, Nirmjaraj Peter